BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Laryngoscope
,
Rapamycin
,
rs7903146
,
SLC12A1
,
Angiogenesis
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CYP2C9
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Liver
Superior cervical ganglion
Appendix
Atrioventricular node
Ciliary ganglion
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Liver regeneration
Injury of liver
Drug resistance to insulin
Drug resistance
Liver cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
2,4-diaminophenol
4-nitrobenzoic acid
2-amino-4-nitrophenol
Nafenopin
Etodolac
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR200A
ZC3H18
NR1I2
FOXE3
NR1I3
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Liver tissues from rats after treatment with different compounds
Liver left lobes from male and female Wistar rats treated with varying doses of acetamide
Normal livers and hepatocellular carcinoma tissues of T1, T3a, and T3b stages
Kidneys and livers of rats treated with crude MCHM, PPH, or 4-methylcyclohexanemethanol
Hepatic progenitor HepaRG cells treated with compounds that cause liver injury
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibition of CYP2C9 by natural products: insight into the potential risk of herb-drug interactions.
An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
CYP2C9-mediated warfarin and milk thistle interaction.
Inhibitory effects of sesamin on CYP2C9-dependent 7-hydroxylation of S-warfarin.
Main contribution of UGT1A1 and CYP2C9 in the metabolism of UR-1102, a novel agent for the treatment…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Genotype on CYP2C9 Drug Interactions
Evaluation of CYP2C9 Activity
Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and…
CYP2C9 Activity Evaluated With a Simple Finger Prick
In Vivo Inhibition Profile of CYP2C9 by Pineapple Juice
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ